Moleculin Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	23.55	43.15	70.9	15.17	10.74	7.13	7.71	5.01	0.03	0.52
Cash & Cash Equivalents	23.55	43.15	70.9	15.17	10.74	7.13	7.71	5.01	0.03	0.52
Cash Growth	-45.42%	-39.15%	367.30%	41.34%	50.48%	-7.52%	54.06%	17724.21%	-94.64%	-
Receivables	0	0	0	0	0	0	0	0	0	0.23
Other Current Assets	2.72	2.45	1.59	2.03	2.75	0.84	0.59	0.22	0	-0.23
Total Current Assets	26.27	45.6	72.5	17.2	13.48	7.97	8.3	5.22	0.03	0.53
Property, Plant & Equipment	0.8	0.68	0.45	0.69	0.6	0.46	0.03	0.02	0	0.02
Goodwill and Intangibles	11.15	11.15	11.15	11.15	11.15	11.15	11.15	11.15	0	0
Other Long-Term Assets	0	0	0	0	0	0	0	0	0	0.23
Total Long-Term Assets	11.94	11.83	11.59	11.83	11.75	11.61	11.18	11.17	0	0.25
Total Assets	38.22	57.42	84.09	29.03	25.24	19.59	19.48	16.39	0.03	0.78
Accounts Payable	2.5	2.1	1.36	1.13	2.15	1.25	0.81	0.4	0.32	1.07
Current Debt	0	0	0	0	0	0	0	0.3	0.45	0
Other Current Liabilities	4.32	2.72	2.26	1.79	1.42	2.63	1.41	0.65	0	0.55
Total Current Liabilities	6.82	4.82	3.62	2.92	3.57	3.88	2.22	1.35	0.77	1.62
Long-Term Debt	0.47	0.34	0.06	0.16	0.28	0	0	0	0	1.63
Other Long-Term Liabilities	4.86	0.08	1.41	8.19	5.82	1.44	0.15	0.09	0	0
Total Long-Term Liabilities	5.33	0.41	1.48	8.35	6.09	1.44	0.15	0.09	0	1.63
Total Liabilities	12.14	5.23	5.1	11.27	9.66	5.31	2.37	1.43	0.77	3.25
Total Debt	0.47	0.34	0.06	0.16	0.28	0	0	0.3	0.45	1.63
Debt Growth	41.49%	431.75%	-60.38%	-42.39%	-	-	-	-34.22%	-72.34%	-
Retained Earnings	-131.6	-101.84	-72.81	-56.92	-39.56	-26.36	-14.48	-4.68	-0.75	-13.84
Comprehensive Income	-0.01	0.01	0.04	0.07	0.03	0.04	0	0	0	0
Shareholders' Equity	26.07	52.19	78.99	17.76	15.57	14.27	17.12	14.96	-0.74	-2.47
Net Cash / Debt	23.08	42.81	70.84	15.01	10.46	7.13	7.71	4.71	-0.42	-1.1
Net Cash / Debt Growth	-46.10%	-39.57%	371.83%	43.55%	46.61%	-7.52%	63.74%	-	-	-
Net Cash Per Share	11.68	22.45	39.54	22.87	23.12	24.79	37.39	43.14	-	-
Working Capital	19.46	40.78	68.88	14.28	9.91	4.1	6.09	3.88	-0.74	-1.1
Book Value Per Share	13.20	27.37	44.09	27.06	34.41	49.59	82.97	137.00	-10.14	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).